Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ...

Vigil Neuroscience Inc ( ($VIGL) ) just unveiled an announcement. On May 22, 2025, Vigil Neuroscience, Inc. held its Annual Meeting of ...

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...

WASHINGTON-The Supreme Court on Thursday granted President Trump's emergency request to fire federal commissioners in the face of a law prohibiting their arbitrary removal, but went out of its way to ...

Here's a recap of the week’s most important stories.

Short interest in Vigil Neuroscience Inc (NASDAQ:VIGL) decreased during the last reporting period, falling from 422.30K to 360.67K. This put 1.01% of the company's publicly available shares short.

Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co ...

French pharma Sanofi has acquired the U.S.-based biotech firm Vigil Neuroscience for $470 million, aiming to bolster its ...

Fintel reports that on May 22, 2025, JMP Securities downgraded their outlook for Vigil Neuroscience (NasdaqGS:VIGL) from ...

Vigil Neuroscience (VIGL) and Sanofi (SNY) announced that it has entered into a definitive merger agreement pursuant to which ...

Sanofi SA made good on its plan to bear down on M&A by agreeing to buy Vigil Neuroscience Inc. for $8 per share (NASDAQ:VIGL). Included in the transaction is a non-tradeable contingent value right ...